Viral Pneumonia
Conditions
Keywords
respiratory virus
Brief summary
The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge.
Detailed description
The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge: * the main goal was to perform a retrospective investigation of the molecular virological tests in a University hospital, in order to identify non-COVID-19 respiratory viruses from the beginning of 2021 to mid-2022 during the circulation of SARS-CoV-2, for public health knowledge; * the secondary aim was to retrospectively analyze, for a small subgroup of patients from an intensive care unit, the files of patients with positive molecular virological tests for non-COVID-19 respiratory viruses from the beginning of 2021 to mid-2022, reporting the following standard-of-care data: (i) the identification of the viruses, (ii) bioclinical features, (iii) medical impact of virological results in real life.
Interventions
OTHERother: Observational
For 18 ICU patients, retrospective collection of routine bioclinical database (ICCA db)
Sponsors
Central Hospital, Nancy, France
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* For adult patients, or minors 'via' parents, able to give consent - 18 intensive care patients
Exclusion criteria
* Non-inclusion in case of refusal
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Occurrence of positive viral PCR assays (not COVID-19) from hospitalizations for respiratory infections. | 18 months, retrospectively | Number of patients with positive virological molecular tests (multiplex respiratory panels) from the beginning of 2021 to mid-2022, with the nature of the viruses detected and the chronology of occurrence of positive tests. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Real-life features of patients in Intensive care (from the whole population - Outcome 1) with positive viral PCR during infectious pneumonia. | 18 months, retrospectively | For the group of patients in Intensive Care: * (i) number of positive molecular virological tests detecting respiratory viruses by FilmArray Pneumonia test * (ii) associated bioclinical data * (iii) medical impact of virological results in real life - progression of the infection and duration of thehospitalization. |
Countries
France
Outcome results
None listed